| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.6 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |